Defining and characterizing the role of the liaison in supporting 2SLGBTQIA+ people to navigate health-service settings: a scoping review protocol.

Objective: This scoping review seeks to identify what is known about the role of liaisons who support two-spirit, lesbian, gay, bisexual, trans, queer, intersex, and asexual (2SLGBTQIA+) people receiving care in health-service settings, and specifically, how the 2SLGBTQIA+ liaison role is defined and characterized.

Introduction: To mitigate the stigma and discrimination experienced by 2SLGBTQIA+ people in health-service settings, a 2SLBGTQIA+ liaison position was initiated at a Canadian hospital. A comprehensive understanding of the 2SLGBTQIA+ liaison role is integral to the implementation of 2SLGBTQIA+ liaison positions in health-service settings globally.

The Role of the Clinical Laboratory in Diagnostic Stewardship and Population Health.

Background: As healthcare identifies new opportunities to provide patient services and moves from volume to value payment models, the clinical laboratory is in an ideal position to serve as a catalyst for these changes. In 2017, the Project Santa Fe Foundation (PSFF) was founded to support the clinical laboratory's role to promote the objectives of population health and value-based healthcare. The initiative, known as Clinical Lab 2.

Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.

GT103 is a first-in-class, fully human, IgG3 monoclonal antibody targeting complement factor H that kills tumor cells and promotes anti-cancer immunity in preclinical models. We conducted a first-in-human phase 1b study dose escalation trial of GT103 in refractory non-small cell lung cancer to assess the safety of GT103 (NCT04314089). Dose escalation was performed using a "3 + 3" schema with primary objectives of determining safety, tolerability, PK profile and maximum tolerated dose (MTD) of GT103.

Management of a Patient With an Anomalous Right Coronary Artery: A Case Report.

Coronary artery anomalies are rare congenital defects that involve abnormalities in the origin, course, or termination of the three main epicardial coronary arteries. Due to the variety of aberrant coronary artery defects, the clinical presentation can differ. Anomalous origins of the right coronary artery include the pulmonary trunk, ascending aorta, left sinus of Valsalva, and a course that traverses between the great vessels.